昂利康：获得恩格列净二甲双胍缓释片（II）药品注册证书

Core Viewpoint - The company, Anglikang (002940.SZ), has received a drug registration certificate from the National Medical Products Administration for its drug, Ertugliflozin Metformin Extended-Release Tablets, which is intended for adult patients with type 2 diabetes who are already undergoing treatment with Ertugliflozin and Metformin to improve blood sugar control [1] Group 1 - The drug is specifically designed for adult patients with type 2 diabetes [1] - The approval of the drug registration certificate is equivalent to passing the consistency evaluation [1] - The pharmaceutical industry is characterized by significant uncertainty in drug sales [1]